ESG & SUSTAINABILITY ADVISORY

Healthcare & Pharmaceuticals

Managing waste, cold chain, and supply chain risk for an industry whose mission is health — and whose footprint is outsized.

Start with a free 2-hour discovery session

THE SECTOR AT A GLANCE

Healthcare providers (hospitals, clinics, diagnostics, long-term care) and pharmaceutical manufacturers (originator and generic drug makers, API producers, biologics and vaccine manufacturers). Providers run asset- and energy-intensive 24/7 operations with cold chains and sterilization; pharma manufacturers are process-industry chemical operations with global, multi-tier supply chains. Together the sector accounts for an estimated 4-5% of global emissions once supply chains are counted. Pakistan's ~$4bn pharma base is heavily import-dependent for raw materials, alongside a fast-growing but fragmented private hospital network.

WHERE THE PRESSURE IS BUILDING

Waste & AMR Risk

Hazardous medical waste and pharma effluent are a direct driver of antimicrobial resistance, and specialized disposal infrastructure is often absent or non-compliant in emerging markets.

Cold Chain & Energy Intensity

Vaccines, biologics and 24/7 hospital operations carry major energy and refrigerant exposure, especially acute in hot climates like Pakistan and the GCC.

Supply Chain Due Diligence

API sourcing faces growing scrutiny over labor conditions, environmental compliance at supplier sites, and falsified/substandard medicine risk.

WHAT REGULATORS EXPECT

Pakistan

  • SECP ESG Disclosure Guidelines – phased mandatory disclosure from 2029 for listed pharma/hospital groups
  • National Hazardous Waste Management Policy – covers handling and disposal of pharma/medical waste
  • DRAP cold chain guidance – draft practice guidelines for vaccine/biologics distribution

Middle East & GCC

  • Abu Dhabi DoH “Part S” – mandatory green infrastructure and waste reduction for facilities
  • Dubai/UAE green building codes – apply to new hospital and clinic developments
  • Saudi Mostadam standards – emerging green-building requirements for new health infrastructure

United States

  • California SB 253 / SB 261 – Scope 1-2 disclosure, climate-risk reporting from 2026
  • Joint Commission Sustainable Healthcare Certification – voluntary but increasingly sought-after accreditation

UK & EU

  • CSRD/ESRS – large pharma manufacturers and hospital groups in scope
  • EU Pharma Package (ERA rules) – environmental risk assessment for marketing authorizations
  • NHS Net Zero Supplier Requirements – Carbon Reduction Plans mandatory for NHS suppliers

HOW SUSTAINADILITY HELPS

Strategic Advisory

  • Net-zero strategy that accounts for healthcare-specific emissions — anesthetic gases, cold chain refrigerants, and purchased pharmaceuticals.

Data & Technology

  • Audit-ready dashboards for SECP and NHS-style supplier Carbon Reduction Plan requirements.

Capacity Building

  • Board briefings on SECP's 2029 deadline and staff training on hazardous waste handling.

Capital Access

  • Green bonds/sukuk and blended finance tied to waste-treatment, energy-intensity, and cold-chain KPIs.
Start with a free 2-hour discovery session
Scroll to Top